(Q46623836)

English

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

scientific article published in April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

1 reference

based on heuristic

inferred from title

computer simulation

1 reference

based on heuristic

inferred from title

Charles F. Gilks

object named as

Charles F Gilks

5

0 references

object named as

Jens D Lundgren

6

0 references

2

object named as

Deenan Pillay

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

Andrew N Phillips

1

object named as

Andrew N Phillips

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

author name string

Alec H Miners

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

Diane E Bennett

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

371

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

9622

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

1443-1451

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modelling the impact of antiretroviral use in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV viral load monitoring in resource-limited regions: optional or necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rolling out antiretrovirals in Africa: there are still challenges ahead.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Balancing effectiveness and access to HIV treatment in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of adherence to antiretroviral therapy: a one-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960624-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)60624-8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18440426

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46623836&oldid=2122733664"